Skip to content
‹ Back to IndustriesFood & Beverage

McDonald’s and GM Boast Positive Q4 Earnings to End 2022 on a High Note

Ba Da Ba Ba Bah, McDonald’s is lovin’ their Q4 earnings. The golden arches were shining bright when McDonald’s reported their fourth-quarter earnings results Tuesday, January 31, 2023. Mcdonald’s beat Wall Street expectations of $5.75 billion in revenue with a reported $5.93 billion. U.S. same-store sales were up, and McDonald’s adjusted earnings per share were…

This story was produced through MarketScale. See how Food & Beverage teams put it to work with Customer Stories & Case Studies.

·
Share

Free workspace

Turn your Food & Beverage expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Ba Da Ba Ba Bah, McDonald’s is lovin’ their Q4 earnings.

The golden arches were shining bright when McDonald’s reported their fourth-quarter earnings results Tuesday, January 31, 2023. Mcdonald’s beat Wall Street expectations of $5.75 billion in revenue with a reported $5.93 billion. U.S. same-store sales were up, and McDonald’s adjusted earnings per share were $2.59 versus the $2.44 expected.

Higher menu prices helped drive McDonald’s Q4 success. A successful marketing collaboration with Cactus Plant Flea Market had customers lining up in the late fall for limited-time Adult Happy Meals. And the fan favorite, the McRib, made its limited return in Q4 to add to McDonald’s strong sales.

Things were also looking bright in Detroit, where GM smashed expectations for Q4 earnings with $33.58 billion in revenue to close out a strong 2022. Looking ahead to 2023, GM predicts a strong sales year as supply-chain issues resolve and inventory levels return to normal.

Nikolay Osadchiy, Associate Professor of Information Systems & Operations Management at Emory’s Goizueta Business School, offered some perspective on these positive Q4 earning results and the factors driving them.

Nikolay’s Thoughts

“Financial markets have been doing well recently, and there are several factors explaining that in my opinion. First, supply chain pressures are easing and trade flows are starting to normalize, so that’s definitely great news, and markets typically react well to supply chains working smoothly.

The second reason is that the American consumer is proving to be fairly resilient. Even though there are some recent cuts in consumer spending that are observed in the data, still, consumer spending remains pretty high. And the third, of course, is that inflationary pressures appear to be easing as well, and the speed of rate hikes by the Federal Reserve is decreasing.

So that said, when we start thinking about individual stocks, the picture is a little bit more nuanced. For example, General Motors recently announced earnings and they beat expectations, the stock price increased. To me, this is mostly the story of supply and demand, so there was lots of residual unmet demand, people wanted to buy cars, but they couldn’t because of various shortages of inventory, of semiconductor chips. Now that supply chains have caught up, people can finally buy cars, and that translates to GM revenue.

Compare that with McDonald’s, for example. McDonald’s in my opinion is really the story of consumer resilience in the face of higher prices. So, despite increased prices, consumers still buy McDonald’s products and that translates to their revenue. Third, just yesterday, Meta had announced earnings and they beat on revenue, but that to me is mostly a story of cost-cutting on Meta’s side and also share buybacks.

So there is a variety of reasons that contribute to market movements. Going back to supply chains, yes, financial markets value supply chains. They like supply chains operating smoothly without glitches, and certainly, that has been factored in, but at the same time, there are a couple of other very significant factors in play, such as inflation, such as consumer spending, rising prices, and Fed policy. So what the net effect is going to be, remains to be seen.”

Your experts belong here

Every story in MarketScale Food & Beverage starts with a company putting its plant managers, quality leads, and R&D teams on the record. Buyers are already reading this topic. The only question is whose experts they find.

Processors and grocery buyers vet suppliers hard, and your operations people are the ones who can satisfy them.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Food & Beverage, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Food & Beverage: are you visible to AI?

Before they reach out, Food & Beverage buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Food & Beverage expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your plant managers, quality leads, and R&D teams into the articles, video, and social content Food & Beverage buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Food & Beverage Insights

Plant-based foods take 35% of texturizer-and-binder demand, IndexBox says

Plant-based foods take 35% of texturizer-and-binder demand, IndexBox says

IndexBox projects the market for protein texturizers and functional binders will reach approximately $8.5 billion by 2035, up from an estimated $4.7 billion in 2025, growing 6.2% a year from 2026 to 2035.

  • 01IndexBox's baseline scenario puts annual growth for texturizers and binders at 6.2% from 2026 to 2035.
  • 02For whole-cut analogues, high‑moisture extrusion capacity is a constraint: FMI cites twin‑screw line capex and cooling‑die throughput limits, while IndexBox says supply resilience also depends on consistent functionality backed by full documentation.

Nov 22, 2026

McCormick, Sysco and Keurig Dr Pepper moves target 2027 dates

McCormick's merger with Unilever Foods is targeted to close in mid-2027. Sysco expects its $29.1 billion Jetro Restaurant Depot purchase to close by the end of its fiscal third quarter in 2027, pending regulatory clearance. Keurig Dr Pepper's two-way split is slated for completion in early 2027.

  • 01Keurig Dr Pepper's split is slated for early 2027, McCormick and Unilever Foods target closing in mid-2027, Sysco expects its Jetro Restaurant Depot deal to close by the end of its fiscal third quarter of 2027, and Abbott plans to spin off its nutrition business by the end of 2027.
  • 02Abbott’s nutrition spin-off may affect suppliers of proteins, vitamins, minerals, sweeteners, flavors, emulsifiers and functional ingredients depending on how the new company handles sourcing and development.
  • 03Coca-Cola's $10 billion US pledge runs through 2030 and its published examples are bottler-owned projects, such as an $84 million automated Orlando distribution center, which points equipment and construction sellers toward bottler-level capital plans.

Nov 21, 2026

FDA's fortification policy leaves the creatine cookie call to brand teams

FDA’s 1980 fortification policy discourages fortifying cookies, cakes and chips and applies only to a fixed list of essential nutrients. Protein falls within its scope, but fiber, creatine and caffeine do not, leaving brand teams to decide where the line is—by audience, brand fit and whether a labeled dose can survive processing.

  • 01The one federal document that tells brands not to fortify cookies has nothing to say about the creatine in one: FDA's policy covers only essential nutrients such as protein, not bioactives or fiber.
  • 02Heat, stability and ingredient interactions can cut a functional dose in half, so whether the format can carry the dose belongs in the go or no-go review before a recipe is locked.
  • 03A protein pastry can be a poor fit for a brand built on clinical doses and a sensible entry product for another brand, especially for shoppers such as GLP-1 users who are making partial diet changes.

Nov 20, 2026

Explore More Food & Beverage Insights

Read more expert perspectives from across Food & Beverage.

Browse Food & Beverage Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Food & Beverage and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512